| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CTP synthase activity | 4.27e-05 | 2 | 131 | 2 | GO:0003883 | |
| GeneOntologyMolecularFunction | bradykinin receptor binding | 1.28e-04 | 3 | 131 | 2 | GO:0031711 | |
| GeneOntologyCellularComponent | negative cofactor 2 complex | 4.02e-05 | 2 | 133 | 2 | GO:0017054 | |
| GeneOntologyCellularComponent | cytoophidium | 1.20e-04 | 3 | 133 | 2 | GO:0097268 | |
| Domain | ARM-type_fold | DOCK3 ZYG11A NCAPD3 XPO1 USP9Y WDFY4 VIRMA SIL1 AP2B1 PIK3CB TERB1 TARBP1 | 4.12e-06 | 339 | 129 | 12 | IPR016024 |
| Domain | Spectrin | 1.74e-05 | 23 | 129 | 4 | PF00435 | |
| Domain | ACTININ_2 | 1.74e-05 | 23 | 129 | 4 | PS00020 | |
| Domain | ACTININ_1 | 1.74e-05 | 23 | 129 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 1.74e-05 | 23 | 129 | 4 | IPR001589 | |
| Domain | ARM-like | 1.83e-05 | 270 | 129 | 10 | IPR011989 | |
| Domain | Spectrin_repeat | 4.51e-05 | 29 | 129 | 4 | IPR002017 | |
| Domain | CTP_synthase_N | 4.73e-05 | 2 | 129 | 2 | IPR017456 | |
| Domain | Erlin1/2 | 4.73e-05 | 2 | 129 | 2 | IPR033294 | |
| Domain | GATase1_CTP_Synthase | 4.73e-05 | 2 | 129 | 2 | IPR033828 | |
| Domain | CTP_synthase | 4.73e-05 | 2 | 129 | 2 | IPR004468 | |
| Domain | CTP_synth_N | 4.73e-05 | 2 | 129 | 2 | PF06418 | |
| Domain | SPEC | 6.72e-05 | 32 | 129 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 6.72e-05 | 32 | 129 | 4 | IPR018159 | |
| Domain | NXF_fam | 1.41e-04 | 3 | 129 | 2 | IPR030217 | |
| Domain | KASH | 2.81e-04 | 4 | 129 | 2 | IPR012315 | |
| Domain | FOXP-CC | 2.81e-04 | 4 | 129 | 2 | PF16159 | |
| Domain | FOXP-CC | 2.81e-04 | 4 | 129 | 2 | IPR032354 | |
| Domain | KASH | 2.81e-04 | 4 | 129 | 2 | PS51049 | |
| Domain | Tap_RNA_bd | 2.81e-04 | 4 | 129 | 2 | PD043466 | |
| Domain | Tap_RNA-bd | 2.81e-04 | 4 | 129 | 2 | IPR015245 | |
| Domain | KASH | 2.81e-04 | 4 | 129 | 2 | SM01249 | |
| Domain | KASH | 2.81e-04 | 4 | 129 | 2 | PF10541 | |
| Domain | Tap-RNA_bind | 2.81e-04 | 4 | 129 | 2 | PF09162 | |
| Domain | GATase | 4.67e-04 | 5 | 129 | 2 | PF00117 | |
| Domain | GATASE_TYPE_1 | 6.97e-04 | 6 | 129 | 2 | PS51273 | |
| Domain | GATASE | 6.97e-04 | 6 | 129 | 2 | IPR017926 | |
| Domain | - | 8.95e-04 | 222 | 129 | 7 | 1.25.10.10 | |
| Domain | CH | 1.06e-03 | 65 | 129 | 4 | SM00033 | |
| Domain | CBFD_NFYB_HMF | 1.29e-03 | 8 | 129 | 2 | PF00808 | |
| Domain | CBFA_NFYB_domain | 1.29e-03 | 8 | 129 | 2 | IPR003958 | |
| Domain | CH | 1.40e-03 | 70 | 129 | 4 | PF00307 | |
| Domain | - | 1.48e-03 | 71 | 129 | 4 | 1.10.418.10 | |
| Domain | CH | 1.64e-03 | 73 | 129 | 4 | PS50021 | |
| Domain | NTF2_DOMAIN | 1.65e-03 | 9 | 129 | 2 | PS50177 | |
| Domain | NTF2 | 1.65e-03 | 9 | 129 | 2 | IPR002075 | |
| Domain | CH-domain | 1.81e-03 | 75 | 129 | 4 | IPR001715 | |
| Domain | - | 2.05e-03 | 10 | 129 | 2 | 3.40.50.880 | |
| Domain | Band_7 | 2.50e-03 | 11 | 129 | 2 | IPR001107 | |
| Domain | Band_7 | 2.50e-03 | 11 | 129 | 2 | PF01145 | |
| Domain | PHB | 2.50e-03 | 11 | 129 | 2 | SM00244 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF438 ZNF473 FOXP2 ZNF423 ZNF521 ZNF880 NUFIP1 ZNF12 ZNF33B ZNF432 FOXP1 ZNF860 ZNF598 | 2.75e-03 | 775 | 129 | 13 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF438 ZNF473 FOXP2 ZNF423 ZNF521 ZNF880 NUFIP1 ZNF12 ZNF33B ZNF432 FOXP1 ZNF860 ZNF598 | 2.81e-03 | 777 | 129 | 13 | PS00028 |
| Domain | Cystatin | 2.99e-03 | 12 | 129 | 2 | IPR027214 | |
| Domain | CYSTATIN | 2.99e-03 | 12 | 129 | 2 | PS00287 | |
| Domain | Class_I_gatase-like | 2.99e-03 | 12 | 129 | 2 | IPR029062 | |
| Domain | Znf_C2H2-like | ZNF438 ZNF473 FOXP2 ZNF423 ZNF521 ZNF880 NUFIP1 ZNF12 ZNF33B ZNF432 FOXP1 ZNF860 ZNF598 | 3.45e-03 | 796 | 129 | 13 | IPR015880 |
| Domain | - | 3.51e-03 | 13 | 129 | 2 | 3.10.450.50 | |
| Domain | Znf_C2H2 | ZNF438 ZNF473 FOXP2 ZNF423 ZNF521 ZNF880 NUFIP1 ZNF12 ZNF33B ZNF432 FOXP1 ZNF860 ZNF598 | 3.80e-03 | 805 | 129 | 13 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF438 ZNF473 FOXP2 ZNF423 ZNF521 ZNF880 NUFIP1 ZNF12 ZNF33B ZNF432 FOXP1 ZNF860 ZNF598 | 3.92e-03 | 808 | 129 | 13 | SM00355 |
| Domain | NTF2-like_dom | 4.69e-03 | 15 | 129 | 2 | IPR032710 | |
| Domain | P-loop_NTPase | SETX THNSL1 MYO9B WRN RAD50 CTPS2 MDN1 ATAD1 CLPB ABCA6 MYO3B TOR3A CTPS1 | 5.84e-03 | 848 | 129 | 13 | IPR027417 |
| Domain | p53-like_TF_DNA-bd | 5.86e-03 | 53 | 129 | 3 | IPR008967 | |
| Domain | CY | 6.02e-03 | 17 | 129 | 2 | SM00043 | |
| Domain | zf-C2H2_6 | 6.20e-03 | 314 | 129 | 7 | PF13912 | |
| Domain | Cystatin_dom | 6.74e-03 | 18 | 129 | 2 | IPR000010 | |
| Domain | Cystatin | 6.74e-03 | 18 | 129 | 2 | PF00031 | |
| Pubmed | CALCOCO2 TRAF3 SETX MAN2B1 ZC3H15 CD109 KEAP1 XPO1 RB1CC1 STAT1 ERLIN1 NAA35 ERLIN2 DST AP2B1 SYNE2 UGGT2 TOR3A CTPS1 MLST8 CNOT1 | 2.71e-08 | 1297 | 134 | 21 | 33545068 | |
| Pubmed | ZNF438 DR1 LZTR1 ZNF473 FOXP2 ZC3H15 ZNF423 BACH1 DRAP1 MEF2D STAT1 NUFIP1 ZC3H10 PER3 FOXP1 ZNF598 | 9.89e-08 | 808 | 134 | 16 | 20412781 | |
| Pubmed | DOCK3 ZNF473 SYNE1 ZNF423 SPTB BACH1 APBA2 ZNF521 USP9Y STAT1 NUFIP1 ODF2L DST CLPB AP2B1 SACS APPL1 MLST8 TARBP1 | 5.31e-07 | 1285 | 134 | 19 | 35914814 | |
| Pubmed | TRAF3 FOXP2 SYNE1 ADGRB2 MSANTD2 KEAP1 VIRMA ARPC4 RAD50 DST MDN1 AP2B1 SYNE2 CDK5RAP2 APPL1 CNOT1 | 1.02e-06 | 963 | 134 | 16 | 28671696 | |
| Pubmed | LZTR1 ZC3H15 STXBP5 IREB2 KEAP1 MEF2D ERLIN1 SIL1 PREB ERLIN2 AP3S1 SYNE2 GPC4 APPL1 UGGT2 ZNF598 | 1.81e-06 | 1007 | 134 | 16 | 34597346 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NCAPD3 SETX HK3 FOXP2 MYO9B DRAP1 MEF2D STAT1 RAD50 GK MDN1 FOXP1 TOR3A ZNF598 | 6.10e-06 | 857 | 134 | 14 | 25609649 |
| Pubmed | NCAPD3 CPNE8 TRAF3 CD109 XPO1 ARPC4 ERLIN1 RAD50 ERLIN2 AP3S1 DST MDN1 ATAD1 CLPB AP2B1 SYNE2 CTPS1 CNOT1 | 1.11e-05 | 1440 | 134 | 18 | 30833792 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | BACH1 WRN ARPC4 ERLIN1 RAD50 DNAAF2 ERLIN2 ATAD1 AP2B1 PTPRQ APPL1 UGGT2 MLST8 METTL25 CNOT1 COA7 TCTN2 | 1.37e-05 | 1321 | 134 | 17 | 27173435 |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 30031127 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15949885 | ||
| Pubmed | Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion. | 1.47e-05 | 2 | 134 | 2 | 30104377 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11122322 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11792814 | ||
| Pubmed | [ACE and AGTR1 genes polymorphisms in left ventricular hypertrophy pathogenesis in humans]. | 1.47e-05 | 2 | 134 | 2 | 15612584 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 23700157 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 1.47e-05 | 2 | 134 | 2 | 24931616 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 12544439 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 17285438 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 28513230 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21319597 | ||
| Pubmed | A Proteome-wide Fission Yeast Interactome Reveals Network Evolution Principles from Yeasts to Human. | 1.47e-05 | 2 | 134 | 2 | 26771498 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22392878 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 19245071 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15923814 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 27639288 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11774217 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22289179 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 19706421 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 24893771 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 18347611 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 18767410 | ||
| Pubmed | Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. | 1.47e-05 | 2 | 134 | 2 | 15056695 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15080371 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 19286759 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16525943 | ||
| Pubmed | Role of ERLINs in the Control of Cell Fate through Lipid Rafts. | 1.47e-05 | 2 | 134 | 2 | 34572057 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 25853299 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 27224915 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11358962 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 23145508 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 28741757 | ||
| Pubmed | RAS genes influence exercise-induced left ventricular hypertrophy: an elite athletes study. | 1.47e-05 | 2 | 134 | 2 | 11079515 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15295089 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11137090 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 12393497 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 18551012 | ||
| Pubmed | Increased risk for ischaemic events is related to combined RAS polymorphism. | 1.47e-05 | 2 | 134 | 2 | 11250978 | |
| Pubmed | Requirement of a corepressor for Dr1-mediated repression of transcription. | 1.47e-05 | 2 | 134 | 2 | 8608938 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22147663 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22768332 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16835267 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15785027 | ||
| Pubmed | Heme regulates gene expression by triggering Crm1-dependent nuclear export of Bach1. | 1.47e-05 | 2 | 134 | 2 | 15175654 | |
| Pubmed | Clustered hydrophobic amino acids in amphipathic helices mediate erlin1/2 complex assembly. | 1.47e-05 | 2 | 134 | 2 | 22020079 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 18231736 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 31195108 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21808598 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16741935 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16775386 | ||
| Pubmed | 174delG mutation in mouse MFRP causes photoreceptor degeneration and RPE atrophy. | 1.47e-05 | 2 | 134 | 2 | 21810984 | |
| Pubmed | Knockdown of FOXP1 promotes the development of lung adenocarcinoma. | 1.47e-05 | 2 | 134 | 2 | 30409062 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 23745680 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 22719026 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15946912 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 17326392 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16109085 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 1.47e-05 | 2 | 134 | 2 | 17267447 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 24055489 | ||
| Pubmed | ACE DD genotype: a predisposing factor for abdominal aortic aneurysm. | 1.47e-05 | 2 | 134 | 2 | 15694792 | |
| Pubmed | ACE and AGTR1 polymorphisms and left ventricular hypertrophy in endurance athletes. | 1.47e-05 | 2 | 134 | 2 | 19997001 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 1.47e-05 | 2 | 134 | 2 | 24718612 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 24586179 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 33025841 | ||
| Pubmed | Genetic polymorphisms of the renin-angiotensin system in breast cancer patients. | 1.47e-05 | 2 | 134 | 2 | 23828384 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 20026870 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 27393035 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 12891302 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 31554351 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 17761684 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 17173513 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 31578382 | ||
| Pubmed | POLYMORPHISM OF ACE AND AT2R1 GENES AS A GENETIC BACKGROUND FOR DIFFERENT TYPES OF ENCEPHALOPATHIES. | 1.47e-05 | 2 | 134 | 2 | 38112365 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 39080710 | ||
| Pubmed | Variance of ACE and AT1 receptor gene does not influence the risk of neonatal acute renal failure. | 1.47e-05 | 2 | 134 | 2 | 11793101 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 18497458 | ||
| Pubmed | Functional dissection of a human Dr1-DRAP1 repressor complex. | 1.47e-05 | 2 | 134 | 2 | 8972183 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 12747597 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 39018973 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11085286 | ||
| Pubmed | Regulation of nuclear import and export of negative cofactor 2. | 1.47e-05 | 2 | 134 | 2 | 19204005 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 20945417 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 17710578 | ||
| Pubmed | Compensation between FOXP transcription factors maintains proper striatal function. | 1.47e-05 | 2 | 134 | 2 | 38761373 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 14521778 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 20560294 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 15498791 | ||
| Pubmed | Regulation of human cytidine triphosphate synthetase 2 by phosphorylation. | 1.47e-05 | 2 | 134 | 2 | 20739275 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 26647308 | ||
| Pubmed | NCAPD3 SETX ZC3H15 BACH1 MSANTD2 XPO1 MEF2D STAT1 RAD50 LENG8 ZC3H10 AP2B1 FOXP1 CTPS1 CNOT1 | 2.43e-05 | 1103 | 134 | 15 | 34189442 | |
| Pubmed | Influence of natriuretic peptide receptor-1 on survival and cardiac hypertrophy during development. | 2.46e-05 | 15 | 134 | 3 | 19782130 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.53e-04 | 4 | 92 | 2 | 1252 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D175|Adult / Lineage, Cell type, age group and donor | 1.25e-07 | 192 | 134 | 8 | 733491e932350e3c216a626cc49c3cd3fe970a82 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 200 | 134 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 200 | 134 | 8 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.71e-07 | 200 | 134 | 8 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.79e-06 | 190 | 134 | 7 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-06 | 191 | 134 | 7 | b270c3dd5952f56b9bdceabe13e298fe6757563b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.52e-06 | 200 | 134 | 7 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.04e-06 | 149 | 134 | 6 | c9334f319a0c943268e54b6f0c9446736172c3a9 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.08e-06 | 160 | 134 | 6 | 5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.08e-05 | 165 | 134 | 6 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.08e-05 | 165 | 134 | 6 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 166 | 134 | 6 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.12e-05 | 166 | 134 | 6 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | Ionocyte|World / Class top | 1.28e-05 | 170 | 134 | 6 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | P15|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.33e-05 | 171 | 134 | 6 | 155e7abd52b84d16146001f6ca49ca0c2294a823 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-05 | 172 | 134 | 6 | c05af6e559f6af0fb15cefa03ffa1413e98a1a4a | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-05 | 172 | 134 | 6 | 953b05f776348cff784e79c93df65841939d880f | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 1.51e-05 | 175 | 134 | 6 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-05 | 176 | 134 | 6 | 33323c97afe509147956b8df9f92ca6b0537e604 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.77e-05 | 180 | 134 | 6 | a0b35067b6f2dbd8145da8bab760e9f650f045b0 | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 1.83e-05 | 181 | 134 | 6 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 181 | 134 | 6 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 181 | 134 | 6 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 1.83e-05 | 181 | 134 | 6 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | Control-CD8+_T_activated|Control / Disease group and Cell class | 2.01e-05 | 184 | 134 | 6 | b86cc48b744b3206880ec1373fe6068e14bf9680 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.33e-05 | 189 | 134 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | Adult|World / Lineage, Cell type, age group and donor | 2.33e-05 | 189 | 134 | 6 | 5cd285bfad973125d46d704fec18b21266a63379 | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.36e-05 | 113 | 134 | 5 | d5f183263cec9922d23cfd38ce9157eef4e58edb | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.36e-05 | 113 | 134 | 5 | 1df80af2c690dac6bfd3dfd7d0052b66c1ae6ea5 | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.36e-05 | 113 | 134 | 5 | 177414e4c859b047a4644664c596a3c22199cdf2 | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE-MP1(C1qb)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.36e-05 | 113 | 134 | 5 | 4b5f545dc02364c5d96a02b0acd68faf1ec4192b | |
| ToppCell | Hippocampus-Hematopoietic-MACROPHAGE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.36e-05 | 113 | 134 | 5 | 927d1071f0719b778f0c3d358c5f96a6ffac6645 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-05 | 190 | 134 | 6 | 05e6af222d0ad97cb69f399a96c9038f9dd989b9 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 192 | 134 | 6 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.62e-05 | 193 | 134 | 6 | 58c590dd6f21bc7ae58ae1729dd574c0f1069592 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 194 | 134 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 194 | 134 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.70e-05 | 194 | 134 | 6 | fc2e0081005c0c496e41197a2d06e4a37708221f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 194 | 134 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 194 | 134 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 194 | 134 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Dendritic|bone_marrow / Manually curated celltypes from each tissue | 2.70e-05 | 194 | 134 | 6 | 768271ae45ff9f6aa3cd9b0ed15fa3caaa68a7b0 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.78e-05 | 195 | 134 | 6 | 6ddce0cce14f737e45b8f57802c6a8ad07686262 | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.78e-05 | 195 | 134 | 6 | e6212373cc3c6c98f76e104e2ac1afa68965cc5f | |
| ToppCell | Mild_COVID-19-T/NK-CD4+_T_2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.86e-05 | 196 | 134 | 6 | e50d03d8428dc4526e4607b6b4e99f0812a0ad31 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.90e-05 | 118 | 134 | 5 | 54930a3faa055bda4a707b93d790b2ac5a360211 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.90e-05 | 118 | 134 | 5 | 18f9c1759df9504962612ec741638ed330c33222 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.90e-05 | 118 | 134 | 5 | 97db1193ecc885f63840663ab969468ce21cba74 | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)-MACROPHAGE_Macrophage.C1qb.Mrc1_(Resident_macrophage)--|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.90e-05 | 118 | 134 | 5 | 0c2fe46dd66e0c9cdf8c2eb66874aca79592248a | |
| ToppCell | Striatum-Hematopoietic-MACROPHAGE-MP1(C1qb)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.90e-05 | 118 | 134 | 5 | 3f8d11e09a7660af9eca5249ad698d9b638d39dd | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 199 | 134 | 6 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | Parenchymal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.11e-05 | 199 | 134 | 6 | a4a9a1c2a34b5a8318a55d1211d6c8661ca9793e | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 199 | 134 | 6 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 3.11e-05 | 199 | 134 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.11e-05 | 199 | 134 | 6 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.11e-05 | 199 | 134 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.11e-05 | 199 | 134 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 3.11e-05 | 199 | 134 | 6 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.11e-05 | 199 | 134 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.20e-05 | 200 | 134 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.20e-05 | 200 | 134 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.20e-05 | 200 | 134 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 3.20e-05 | 200 | 134 | 6 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.20e-05 | 200 | 134 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.20e-05 | 200 | 134 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 3.20e-05 | 200 | 134 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.20e-05 | 200 | 134 | 6 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.20e-05 | 200 | 134 | 6 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 121 | 134 | 5 | e82c9e10b98c8d7ad828cf8ac19a2342014be2ba | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.62e-05 | 130 | 134 | 5 | 92913960e4367261ba08a405b61a421bc5e18169 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.54e-05 | 148 | 134 | 5 | 1d9fa6b2ee9feaed39c63d44e638b5c0942d947c | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.10e-05 | 150 | 134 | 5 | 98fdc6bdfde84d680e11d8727502b79afbf64303 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.03e-04 | 154 | 134 | 5 | ea5d0da5dd8ccfc19969aec35f044db77d589f54 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.03e-04 | 154 | 134 | 5 | e94cd11488003347120eacd3ced0a8923ed09ccc | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 156 | 134 | 5 | dd41ed918b07fa248da458a629b3c53cb7ea8764 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-04 | 156 | 134 | 5 | abf9dd075b1ca8f613c660cc82f8a5af071fb6ab | |
| ToppCell | facs-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 156 | 134 | 5 | f532ef4e92ac7661b1a8a4f2e98d80ce8d4e3655 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 156 | 134 | 5 | da4f35353a84d919e683554932f110e29568df33 | |
| ToppCell | facs-Spleen-nan-3m-Myeloid-granulocyte|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 156 | 134 | 5 | f1e25ff85c5f2f8555f9fb5ae5daed7ddb418fd1 | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_TEM|URO / Disease, Lineage and Cell Type | 1.23e-04 | 160 | 134 | 5 | e406f77b1c1a01d74f39ba65f99d5f8c7d75faf1 | |
| ToppCell | CV-Mild-4|Mild / Virus stimulation, Condition and Cluster | 1.23e-04 | 160 | 134 | 5 | 2e24f8de5086b086863d3bf4d9afbd9bc93f4d5e | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-04 | 161 | 134 | 5 | 7e0b8119cea208c0b4a0dffdf94ff6137d0b4c90 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_8|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-04 | 162 | 134 | 5 | 2fd6e8f48b48d509a7533cec2f79089513c34a2f | |
| ToppCell | URO-Lymphocyte-T_NK-MAIT|URO / Disease, Lineage and Cell Type | 1.38e-04 | 164 | 134 | 5 | cb42a70433b3968caca67f7aa98ea536cd90a0bc | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 164 | 134 | 5 | f4de9f18134a06f3d7fcf5b50b8e21c1506e2083 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Basophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 164 | 134 | 5 | dc22b1fef49c1557a0b63c536eaba574dfcab715 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-CD4_TEM|Leuk-UTI / Disease, Lineage and Cell Type | 1.42e-04 | 165 | 134 | 5 | 08285c09de16ed4f488abb655a22f54bc07968ae | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 168 | 134 | 5 | d72cd8238fa793bb3e4add4c59eaaaadcea9930d | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 1.55e-04 | 168 | 134 | 5 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-04 | 168 | 134 | 5 | 2eed7dc1a2aff11be024823c4323c42bc94362f6 | |
| Disease | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy | 5.41e-05 | 3 | 126 | 2 | cv:C1846574 | |
| Disease | nanophthalmos (is_implicated_in) | 5.41e-05 | 3 | 126 | 2 | DOID:0080634 (is_implicated_in) | |
| Disease | Renal Tubular Dysgenesis With Choanal Atresia And Athelia | 1.08e-04 | 4 | 126 | 2 | C2678367 | |
| Disease | Renal tubular dysgenesis of genetic origin | 1.08e-04 | 4 | 126 | 2 | cv:C5681536 | |
| Disease | RENAL TUBULAR DYSGENESIS | 1.08e-04 | 4 | 126 | 2 | 267430 | |
| Disease | Allanson Pantzar McLeod syndrome | 1.08e-04 | 4 | 126 | 2 | C0266313 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 1.08e-04 | 4 | 126 | 2 | cv:CN293514 | |
| Disease | Renal tubular dysgenesis | 1.08e-04 | 4 | 126 | 2 | cv:C0266313 | |
| Disease | specific developmental disorder (implicated_via_orthology) | 1.08e-04 | 4 | 126 | 2 | DOID:0060038 (implicated_via_orthology) | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.79e-04 | 5 | 126 | 2 | C1450051 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.79e-04 | 5 | 126 | 2 | C0410190 | |
| Disease | glucose metabolism disease (implicated_via_orthology) | 2.30e-04 | 28 | 126 | 3 | DOID:4194 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy | 2.68e-04 | 6 | 126 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 2.68e-04 | 6 | 126 | 2 | C0410189 | |
| Disease | neuropeptide W measurement | 2.68e-04 | 6 | 126 | 2 | EFO_0801835 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 3.75e-04 | 7 | 126 | 2 | C0751337 | |
| Disease | IGA Glomerulonephritis | 4.13e-04 | 34 | 126 | 3 | C0017661 | |
| Disease | Ataxias, Hereditary | 4.98e-04 | 8 | 126 | 2 | C0004138 | |
| Disease | renovascular hypertension (implicated_via_orthology) | 6.39e-04 | 9 | 126 | 2 | DOID:1591 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ZNF438 HK3 NSD2 SYNE1 CD109 KEAP1 RB1CC1 STAT1 PER3 PIK3CB SYNE2 ZNF432 APPL1 | 7.00e-04 | 1074 | 126 | 13 | C0006142 |
| Disease | venous thromboembolism, von Willebrand factor measurement | 7.73e-04 | 42 | 126 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | Colorectal Carcinoma | 8.84e-04 | 702 | 126 | 10 | C0009402 | |
| Disease | Microphthalmos | 9.70e-04 | 11 | 126 | 2 | C0026010 | |
| Disease | Celiac Disease | 1.07e-03 | 47 | 126 | 3 | C0007570 | |
| Disease | pulmonary fibrosis (implicated_via_orthology) | 1.16e-03 | 12 | 126 | 2 | DOID:3770 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.16e-03 | 12 | 126 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | intercellular adhesion molecule 5 measurement | 1.37e-03 | 13 | 126 | 2 | EFO_0008164 | |
| Disease | intermediate coronary syndrome (is_marker_for) | 1.37e-03 | 13 | 126 | 2 | DOID:8805 (is_marker_for) | |
| Disease | chronotype measurement | CALCOCO2 DOCK3 CPNE8 STON1 FOXP2 ZNF521 PER3 AP2B1 NXF5 PLXNA4 FOXP1 | 1.44e-03 | 882 | 126 | 11 | EFO_0008328 |
| Disease | Spastic Paraplegia, Hereditary | 1.59e-03 | 14 | 126 | 2 | C0037773 | |
| Disease | age at first birth measurement | 1.78e-03 | 120 | 126 | 4 | EFO_0009101 | |
| Disease | hyperinsulinism (biomarker_via_orthology) | 1.83e-03 | 15 | 126 | 2 | DOID:2018 (biomarker_via_orthology) | |
| Disease | serum IgG glycosylation measurement | 1.87e-03 | 523 | 126 | 8 | EFO_0005193 | |
| Disease | sarcoidosis (is_implicated_in) | 2.09e-03 | 16 | 126 | 2 | DOID:11335 (is_implicated_in) | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 2.50e-03 | 63 | 126 | 3 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | syndrome (implicated_via_orthology) | 2.65e-03 | 18 | 126 | 2 | DOID:225 (implicated_via_orthology) | |
| Disease | macrophage inflammatory protein 1b measurement | 2.80e-03 | 136 | 126 | 4 | EFO_0008219 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 2.95e-03 | 19 | 126 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | factor VIII measurement, Ischemic stroke | 2.95e-03 | 19 | 126 | 2 | EFO_0004630, HP_0002140 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 3.27e-03 | 20 | 126 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 3.27e-03 | 20 | 126 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | ceramide measurement | 3.44e-03 | 235 | 126 | 5 | EFO_0010222 | |
| Disease | COVID-19 (is_implicated_in) | 3.60e-03 | 21 | 126 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | resting heart rate | 3.88e-03 | 149 | 126 | 4 | EFO_0004351 | |
| Disease | Autosomal Recessive Primary Microcephaly | 3.95e-03 | 22 | 126 | 2 | C3711387 | |
| Disease | wellbeing measurement, alcohol consumption measurement | 3.95e-03 | 74 | 126 | 3 | EFO_0007869, EFO_0007878 | |
| Disease | breast cancer (is_implicated_in) | 3.97e-03 | 150 | 126 | 4 | DOID:1612 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHFDKNFVQLCLSAE | 151 | O60241 | |
| EFLSVHNIEESCFQF | 111 | O14867 | |
| QFQIKECHLNADTVS | 851 | P63010 | |
| SFIIQFQFHEALCQA | 1131 | P12821 | |
| HRNVFFIENTNITVC | 166 | P30556 | |
| TLIFNKIHHELNQFC | 116 | O75477 | |
| VKHNFNLEEYSLSQC | 1566 | Q8N139 | |
| DLIHFSNSENCKELQ | 556 | Q99767 | |
| FHLVSKRDENVCNFL | 36 | Q92572 | |
| ERELHKQVNCFFSVF | 106 | Q9H112 | |
| FQLQKHSQCSEAIIT | 1131 | Q96SN8 | |
| QQCLFLHFQANTKTF | 486 | Q6P1R3 | |
| TTSHLKQCIELEQQF | 66 | Q14919 | |
| AHIQELSCLFQSEKA | 156 | Q9ULJ1 | |
| VSKAVLNNVIFCHQE | 146 | Q92878 | |
| VDHSLQIDFSKCAIQ | 126 | P48200 | |
| CENSNDTVKLKINFH | 551 | Q14207 | |
| CLHQTVQQFKRFIEN | 1026 | Q9NRD9 | |
| LQFHNFSLEAQDECK | 341 | Q9BY79 | |
| HFRTFVQKEQCDFSN | 821 | Q8TDY2 | |
| RLDDCDFQTNHTLKQ | 106 | O76096 | |
| GFCNLQTLKDFQHID | 96 | Q8IYW4 | |
| HFNSKDELIQANVCS | 131 | Q96AD5 | |
| DVSLDELKNFVHAQC | 2876 | Q9NU22 | |
| LFSQHFENCRDTSKI | 231 | Q8NG48 | |
| EHCLNFVVKESHFNQ | 596 | Q8N653 | |
| VIKDHVTNCAFSFQN | 816 | Q9NVR5 | |
| FQEENHICTFKQTLE | 1091 | Q6UXM1 | |
| DDFKSVVSEQCNHLQ | 81 | O75487 | |
| QFSSELQQCLQHTEK | 3386 | Q03001 | |
| HQEENLCFENSFSLI | 301 | Q8N6Q8 | |
| DHEEFNQCQTQLKSL | 636 | Q96PV6 | |
| LQQFSKVIDELSSCH | 86 | Q9UKG1 | |
| DATAFCAELLHVKQQ | 471 | Q9NRM6 | |
| HQKAVVCLAFNDSVL | 311 | Q9BVC4 | |
| CVHSVQANSEFFQIL | 86 | P56645 | |
| QFVFDIHKNSITDAC | 1756 | Q9HCM2 | |
| DENQKICIFVSHFTA | 76 | Q9H1B4 | |
| DFHNTAQCIIDQFIS | 736 | Q9ULD0 | |
| FLHNQICRQFTKIEA | 51 | A0A1B0GUS0 | |
| ICEDFGQFLKHLNNE | 356 | O15409 | |
| AASQFLVFCQKHRDE | 456 | O96028 | |
| VCEDFQSFLKHLNSE | 316 | Q9H334 | |
| QLAEVCAFFKHQIVQ | 516 | Q7L4E1 | |
| FVQLFVHDKSRCQLE | 186 | Q6IPT2 | |
| FDHIVDCIVDFQQKQ | 581 | P52790 | |
| FIHLISSEANEICNK | 46 | Q01658 | |
| LQLDFCDSNVIDHFT | 161 | A6NM76 | |
| IFNKIHHELNQFCSV | 116 | O94905 | |
| FLQHVEELCTNNNLK | 2021 | Q9UMZ3 | |
| QDEQKFHCLVLSQSL | 106 | O75144 | |
| RVLQESCEFFLKHNS | 521 | O60353 | |
| AKIHECFQQVLQALS | 116 | P20848 | |
| KDDLNHVDLNVCTSF | 1291 | Q6YHK3 | |
| CDTHFQHLLDNFQSK | 956 | Q8IZD9 | |
| VNSHFITAEECLKLF | 721 | Q5THR3 | |
| ISVFQDFLFTHECEQ | 261 | P32246 | |
| QFTNKCHIAFAALEA | 391 | P32189 | |
| DHCHFSQVIFNSVEK | 16 | Q13137 | |
| KLEKHINQEAFNCFF | 176 | Q6ZWL3 | |
| FKDHFTFCQQLNISI | 486 | O00754 | |
| CSVNFSAEHFSQDLK | 6 | Q9NWL6 | |
| KQEEFFNLSHCQLVT | 216 | Q14145 | |
| FCHSELIQLVNKELN | 571 | Q9H078 | |
| DLTSKNCHLFVNLQS | 66 | Q9NZJ4 | |
| EIVTQFTTQFLKLHC | 161 | H0Y7S4 | |
| LHKNLFFSFVCNSVV | 176 | Q16602 | |
| NLSKHDFLGQVFCTL | 106 | Q86YQ8 | |
| CTFHLEKNINQSLLE | 66 | P0C7X4 | |
| TANFVNAISFEHVCK | 326 | Q7L1W4 | |
| CEIALIIFNHSNKLF | 41 | Q14814 | |
| DDENQKICIFVNHST | 186 | Q9GZY0 | |
| QSCVQKRNIFKEDFH | 251 | Q9UPX6 | |
| KVQLRFQHSQDVSDC | 101 | Q494U1 | |
| DFKCKTLQNREHETN | 171 | P42224 | |
| HFQKNFVCLENCSLQ | 151 | Q9UQK1 | |
| FQFFLQKTEHSCVIN | 186 | Q8IYX1 | |
| LQSFLLQHQTFLEKC | 7451 | Q8NF91 | |
| KFEAFQRQVHECLTQ | 8041 | Q8NF91 | |
| LTNIEHFSECDVQAK | 8131 | Q8NF91 | |
| NTFQCRINIEHALTF | 86 | Q8WXH0 | |
| NFLECSQRHSFQISL | 276 | P32249 | |
| FQFKVKRENFCNIHV | 166 | P17812 | |
| NEELVIFSFHENNCK | 871 | Q7Z333 | |
| IFSFHENNCKIQEFH | 876 | Q7Z333 | |
| FTFCLSHQNLKEFAL | 26 | Q9H173 | |
| LEVIKHFCQTNSVQT | 1216 | Q14191 | |
| KLIVAVHFENCQDVF | 196 | P42338 | |
| TEENCLEFQESFKHI | 91 | Q86XK3 | |
| EIQETLQSEHFQLCK | 36 | Q5T5C0 | |
| SKDAAFQNVLTHVCL | 346 | Q8NBU5 | |
| CLENFSSQVVERHNK | 21 | P59998 | |
| HFTDEQRFNITSKIC | 1106 | P42695 | |
| KVLKFNCEENQHSDS | 56 | Q96BR5 | |
| KDFHQTQFLIQECAL | 66 | A5YKK6 | |
| CALKTIFAQFQHSRE | 76 | Q70EK8 | |
| LQKVVCFNHDNTLLA | 156 | Q9HCU5 | |
| FQFKAKRENFCNIHV | 166 | Q9NRF8 | |
| NLSLFLCTFLKEHDQ | 321 | O14980 | |
| KSIQSLHNQICSFEI | 286 | Q13114 | |
| ECDKVFSNSSNLVQH | 216 | Q6PDB4 | |
| KIQTLDHNFEYSICQ | 211 | Q06732 | |
| SCTLFQDIFQHLDKA | 336 | Q9UNW1 | |
| ELDCSFTAHEKIVQF | 201 | Q9UHK0 | |
| EHQQCLAVFSRVKFT | 226 | Q5VZE5 | |
| HFHKCVNVQEFEQSR | 486 | Q9Y6Q2 | |
| LCQEVFDSKVSIQLH | 726 | Q96K83 | |
| CFTVFVQANKLQQHI | 1261 | Q96K83 | |
| CPQKFFFQTELQNHT | 1291 | Q96K83 | |
| NVFHKASDSVLCIQV | 391 | Q6ZS81 | |
| ICASNQNHVLTDFIK | 531 | Q8IYQ7 | |
| LAKSDEHFVQNCTSL | 856 | Q70Z35 | |
| NEIFLIHFITFCQEK | 56 | Q6BDI9 | |
| SHTLAQCLGFQEFQK | 1161 | P11277 | |
| GDQQDRHVSKLIFCF | 11 | Q8WVE6 | |
| KANQVVIHEDFIQSC | 806 | O00507 | |
| TQLNTDLTAFLQKHC | 131 | P57060 | |
| TAKQQELLSAHTDFC | 821 | Q86UK7 | |
| QTKSLCLFRENHDTF | 116 | O94892 | |
| TKFLSIQDEFCHFLQ | 311 | Q5W5X9 | |
| AQHCFIKSIQSEQIN | 846 | Q6PGP7 | |
| QEVHIREKSFQCNES | 221 | A6NHJ4 | |
| ECQKAFQKDTVFVNH | 221 | P17014 | |
| SLQCISDKQFQHLSV | 1496 | Q13395 | |
| QCDLKFSNFESFQTH | 636 | Q2M1K9 | |
| QCKEDFDSQESLLQH | 666 | Q2M1K9 | |
| TQIVCKHFLEAIENN | 176 | Q8WU90 | |
| NIFRTHQLFCQDVLK | 851 | Q9NYU1 | |
| VSNLGVSKNEFIFCH | 66 | Q96K80 | |
| VSKNEFIFCHDFQNK | 71 | Q96K80 | |
| RETQQLCHQTLFIFD | 221 | Q9H497 | |
| DFSSNQIFLVCEHEL | 176 | O60602 | |
| QTLQCITELFSHFQR | 766 | Q69YN4 | |
| LSVFNVCFHTEDLAN | 186 | Q6WRX3 | |
| CKHFIENQGLQIFIQ | 551 | Q6WRX3 | |
| RCQITAQSFAEIKFH | 651 | Q7Z4V0 | |
| CNQNLHEETTFEKNF | 521 | Q8NA31 | |
| AFLHNFDVKCVTNLE | 311 | Q96GX1 | |
| TQNCFLNSEIHQVTK | 466 | Q9BYX2 | |
| ECKETFSDNNRLVQH | 491 | Q8WTR7 | |
| FNHFISQCLIKDFER | 266 | Q8WXR4 | |
| FQNKHIQSCKEESAL | 1161 | Q13459 | |
| DDAFVCQKKNHFQVT | 391 | Q9Y2G1 |